A Review of Behavioral Tests to Evaluate Different Types of Anxiety and Anti-anxiety Effects

키워드

참고문헌 (69)

1. 왕성민, "The Efficacy and Safety of Clonazepam in Patients with Anxiety Disorder Taking Newer Antidepressants: A Multicenter Naturalistic Study", Clinical Psychopharmacology and Neuroscience, 14(2), pp.177~183 (2016), 대한정신약물학회
2. Navarro JF, "Anxiolytic-like activity of SB-205384 in the elevated plus-maze test in mice", Psicothema, 18, pp.100~104 (2006)
3. "Mental health" (2018)[URL]
4. Rector NA, "Anxiety disorders: an information guide", pp.5~6 (2008), Centre for Addiction and Mental Health
5. Komada M, "Elevated plus maze for mice", J Vis Exp, (22), pp.e1088~ (2008)
6. Pawlak CR, "The elevated plus-maze test : differential psychopharmacology of anxiety-related behavior", Emot Rev, 4, pp.98~115 (2012)
7. Bourin M, "Animal models for screening anxiolytic-like drugs : a perspective", Dialogues Clin Neurosci, 17, pp.295~303 (2015)
8. Mulder GB, "The elevated plus-maze", Contemp Top Lab Anim Sci, 43, pp.39~40 (2004)
9. "Elevated plus maze"[URL]
10. Leo LM, "Elevated plus maze test to assess anxiety-like behavior in the mouse", Bio-Protoc, 4, pp.e1211~ (2014)
11. Albani SH, "Behavior in the elevated plus maze is differentially affected by testing conditions in rats under and over three weeks of age", Front Behav Neurosci, 9, pp.31~ (2015)
12. Walf AA, "The use of the elevated plus maze as an assay of anxiety-related behavior in rodents", Nat Protoc, 2, pp.322~328 (2007)
13. Bourin M, "The mouse light", dark box test, 2003, pp.463, 55~65
14. Patel PK, "Pharmacological models to appraisement of antianxiety activity in experimental animals", Int J Green Pharm, 12(3Suppl), pp.S449~S457 (2018)
15. Arrant AE, "Use of the light", dark test for anxiety in adult and adolescent male rats, 2013, pp.256, 119~127
16. Fraser LM, "Measuring anxiety- and locomotion-related behaviours in mice: a new way of using old tests", Psychopharmacology(Berl), 211, pp.99~112 (2010)
17. Roedel A, "Effects of light or dark phase testing on behavioural and cognitive performance in DBA mice", Lab Anim, 40, pp.371~381 (2006)
18. Thiels E, "A reliable behavioral assay for the assessment of sustained photophobia in mice", Curr Eye Res, 33, pp.483~491 (2008)
19. Ibironke GF, "Cholinergic modulation of restraint stress induced neurobehavioral alterations in mice", Afr J Biomed Res, 17, pp.181~185 (2014)
20. Hascoët M, "The mouse light-dark paradigm : a review", Prog Neuropsychopharmacol Biol Psychiatry, 25, pp.141~166 (2001)
21. Çalışkan H, "Marble burying test analysis in terms of biological and non-biological factors", J Appl Biol Sci, 11, pp.54~57 (2017)
22. Prajapati RP, "Effect of methanolic extract of Lagenaria siceraria(Molina)Standley fruits on marble-burying behavior in mice : Implications for obsessive-compulsive disorder", Pharmacogn Res, 3, pp.62~ (2011)
23. Angoa-Pérez M, "Marble burying and nestlet shredding as tests of repetitive, compulsive-like behaviors in mice", J Vis Exp, (82), pp.50978~ (2013)
24. Taylor GT, "Marble burying as compulsive behaviors in male and female mice", Acta Neurobiol Exp(Wars), 77, pp.254~260 (2017)
25. Thomas A, "Marble burying reflects a repetitive and perseverative behavior more than novelty-induced anxiety", Psychopharmacology(Berl), 204, pp.361~373 (2009)
26. Njung’e K, "Evaluation of marble-burying behavior as a model of anxiety", Pharmacol Biochem Behav, 38, pp.63~67 (1991)
27. Chaudhary S, "Study of agomelatine for the reduction of marble buying behavior in brain disorder", J Adv Pharm Edu Res, 6, pp.1~5 (2016)
28. Nardo M, "Cannabidiol reverses the mCPP-induced increase in marble-burying behavior", Fundam Clin Pharmacol, 28, pp.544~550 (2014)
29. Wolmarans de W, "Of mice and marbles : novel perspectives on burying behavior as a screening test for psychiatric illness", Cogn Affect Behav Neurosci, 16, pp.551~560 (2016)
30. Diniz JB, "Outlining new frontiers for the comprehension of obsessive-compulsive disorder : a review of its relationship with fear and anxiety", Braz J Psychiatry, 34(Suppl 1), pp.S81~S91 (2012)
31. Homma C, "Physical properties of bedding materials determine the marble burying behavior of mice(C57BL", 6J), 2009, pp.3, 34~39
32. Cryan JF, "The age of anxiety : role of animal models of anxiolytic action in drug discovery", Br J Pharmacol, 164, pp.1129~1161 (2011)
33. Wernecke KE, "The olfactory hole-board test in rats : a new paradigm to study aversion and preferences to odors", Front Behav Neurosci, 9, pp.223~ (2015)
34. File SE, "The reliability of the hole-board apparatus", Psychopharmacologia, 44, pp.47~51 (1975)
35. Brown GR, "The exploratory behaviour of rats in the hole-board apparatus: is head-dipping a valid measure of neophilia?", Behav Processes, 78, pp.442~448 (2008)
36. Takeda H, "Changes in head-dipping behavior in the hole-board test reflect the anxiogenic and", or anxiolytic state in mice, 1998, pp.350, 21~29
37. Dutt Garg V, "Experimetal model for antiaxiety acyivity : a review", Pharmacologyonline, 1, pp.394~404 (2011)
38. Labots M, "The modified hole board--measuring behavior, cognition and social interaction in mice and rats", J Vis Exp, (92), pp.e52529~ (2015)
39. Ohl F, "The modified hole board as a differential screen for behavior in rodents", Behav Res Methods Instrum Comput, 33, pp.392~397 (2001)
40. Kavaya Sree K, "Screening of behavioural, muscle co ordination and anxiolytic activities of methanolic extract of holoptelea integrifolia(ROXB)", Int Res J Pharm, 4, pp.90~94 (2013)
41. Takem LP, "Exploratory and anxiety potentials of aqueous extract of Phragmanthera capitata", J Phytopharmacol, 3, pp.400~404 (2014)
42. Brown RE, "Developing standardized behavioral tests for knockout and mutant mice", ILAR J, 41, pp.163~174 (2000)
43. Hall CS, "Emotional behavior in the rat. I. Defecation and urination as measures of individual differences in emotionality", J Comp Psychol, 18, pp.385~403 (1934)
44. Seibenhener ML, "Use of the Open Field Maze to measure locomotor and anxiety-like behavior in mice", J Vis Exp, (96), pp.e52434~ (2015)
45. Stanford SC, "The Open Field Test : reinventing the wheel", J Psychopharmacol, 21, pp.134~135 (2007)
46. Royce JR, "On the construct validity of open-field measures", Psychol Bull, 84, pp.1098~1106 (1977)
47. Rodgers RJ, "Animal models of 'anxiety': where next?", Behav Pharmacol, 8, pp.477~496 (1997)
48. Tatem KS, "Behavioral and locomotor measurements using an open field activity monitoring system for skeletal muscle diseases", J Vis Exp, (91), pp.51785~ (2014)
49. "The open field and animal behavior" (2015)[URL]
50. Prut L, "The open field as a paradigm to measure the effects of drugs on anxiety-like behaviors : a review", Eur J Pharmacol, 463, pp.3~33 (2003)
51. Handley SL, "Effects of alpha-adrenoceptor agonists and antagonists in a maze-exploration model of ‘fear’-motivated behaviour", Naunyn Schmiedebergs Arch Pharmacol, 327, pp.1~5 (1984)
52. Wilks LJ, "Evidence for simultaneous anxiolytic and aversive effects several hours after administration of sodium phenobarbitone to the rat", Neuropsychobiology, 19, pp.86~89 (1988)
53. Filip M, "The anxiolytic-like effects of 5-hydroxytryptamine3(5-HT3)receptor antagonists", Pol J Pharmacol Pharm, 44, pp.261~269 (1992)
54. Hogg S, "A review of the validity and variability of the elevated plus-maze as an animal model of anxiety", Pharmacol Biochem Behav, 54, pp.21~30 (1996)
55. Braun AA, "Comparison of the elevated plus and elevated zero mazes in treated and untreated male Sprague-Dawley rats : effects of anxiolytic and anxiogenic agents", Pharmacol Biochem Behav, 97, pp.406~415 (2011)
56. Moser PC, "Characterization of MDL 73005EF as a 5-HT1A selective ligand and its effects in animal models of anxiety : comparison with buspirone, 8-OH-DPAT and diazepam", Br J Pharmacol, 99, pp.343~349 (1990)
57. Lister RG, "The use of a plus-maze to measure anxiety in the mouse", Psychopharmacology(Berl), 92, pp.180~185 (1987)
58. Hascoët M, "The influence of buspirone, and its metabolite 1-PP, on the activity of paroxetine in the mouse light", dark paradigm and four plates test, 2000, pp.67, 45~53
59. Bourin M, "A schematic representation of the psychopharmacological profile of antidepressants", Prog Neuropsychopharmacol Biol Psychiatry, 20, pp.1389~1402 (1996)
60. De Angelis L, "The anxiolytic-like properties of two selective MAOIs, moclobemide and selegiline, in a standard and an enhanced light", dark aversion test, 2000, pp.65, 649~653
61. Crawley J, "Preliminary report of a simple animal behavior model for the anxiolytic effects of benzodiazepines", Pharmacol Biochem Behav, 13, pp.167~170 (1980)
62. Treit D, "Conditioned defensive burying : a new paradigm for the study of anxiolytic agents", Pharmacol Biochem Behav, 15, pp.619~626 (1981)
63. Czech DA, "Nitrous oxide induces an anxiolytic-like effect in the conditioned defensive burying paradigm, which can be reversed with a benzodiazepine receptor blocker", Psychopharmacology(Berl), 113, pp.211~216 (1993)
64. Picazo O, "Anti-anxiety effects of progesterone and some of its reduced metabolites : an evaluation using the burying behavior test", Brain Res, 680, pp.135~141 (1995)
65. Joel D, "Current animal models of obsessive compulsive disorder : a critical review", Prog Neuropsychopharmacol Biol Psychiatry, 30, pp.374~388 (2006)
66. Sillaber I, "Profiling of behavioral changes and hippocampal gene expression in mice chronically treated with the SSRI paroxetine", Psychopharmacology(Berl), 200, pp.557~572 (2008)
67. Thoeringer CK, "Long-term anxiolytic and antidepressant-like behavioural effects of tiagabine, a selective GABA transporter-1(GAT-1)inhibitor, coincide with a decrease in HPA system activity in C57BL", 6 mice, 2010, pp.24, 733~743
68. Ohl F, "Differential analysis of behavior and diazepam-induced alterations in C57BL", 6N and BALB, J Psychiatr Res, pp.2001, 35[DOI]
69. Zimcikova E, "Behavioral effects of antiepileptic drugs in rats: are the effects on mood and behavior detectable in open-field test?", Seizure, 52, pp.35~40 (2017)

관련 논문AI추천